FDA

Legal News

In case you missed it

Sponsors

Mergers & Acquisitions

Becton Dickinson

Becton Dickinson closes Cellular Research buy

Becton Dickinson & Co. (NYSE:BDX) said Tuesday it closed its purchase of biotech firm Cellular Research for an undisclosed price. Cellular Research develops tools for parallel single cell genetic analysis based upon its proprietary molecular indexing technology, according to Franklin Lakes, N.J.-based Becton Dickinson. “The acquisition of Cellular Research, combined with our existing cell sorting technology, […]

Pfizer to acquire Hospira

FTC clears Pfizer’s $15B Hospira buy

Pfizer (NYSE:PFE) said Monday it won approval from the Federal Trade Commission for its $15 billion acquisition of Hospira (NYSE:HSP). The clearance came with a caveat –Pfizer must divest itself of its Acetylcysteine, Clindamycin, Voriconazole and Melphalan sterile injectable assets, according to the company. The news from the FTC came August 21, according to an SEC filing from […]

Cardinal Health

Cardinal Health to buy NaviHealth for $410m

Cardinal Health (NYSE:CAH) said it paid $290 million for a majority stake in post-acute care management firm NaviHealth, in a 4-year deal worth $410 million. The $290 million payout gives Dublin, Ohio-based Cardinal a 71% share in NaviHealth, the company said. NaviHealth’s Brentwood, Tenn.-based management team will continue to lead the business and principal investor Welsh, Carson, […]

Abbott

Abbott denies St. Jude Medical buyout report

Abbott (NYSE:ABT) today denied reports that it’s prepping a $25 billion offer for St. Jude Medical (NYSE:STJ), but the rumor nevertheless propelled STJ shares up over 10% this morning. Investors were sparked by a Financial Times report of the potential offer. Abbott is working with banks on a cash-and-stock proffer, the newspaper report, citing people familiar […]

Edwards Lifesciences acquires CardiAQ Valve Technologies

Edwards Lifesciences closes $400m CardiAQ Valve buyout

Edwards Lifesciences (NYSE:EW) said yesterday that it closed the $400 million buyout of CardiAQ Valve Technologies and its transcatheter mitral valve implant. The deal for CardiAQ Valve, which like Edwards is based in Irvine, Calif., included an up-front payment of $350 million in cash and another $50 million pegged to “achievement of a European regulatory milestone,” Edwards said. Edwards is […]

3M Co., Polypore

3M pays $1B for Polypore’s separations media biz

3M Co. (NYSE:MMM) said today that it paid $1 billion for the Polypore’s (NYSE:PPO) separations media business, which makes membranes and modules for blood treatment, ultrafiltration and gas transfer. St. Paul, Minn.-based 3M said Polypore’s separation media segment puts up annual sales of roughly $210 million. The acquisition is expected to dilute earnings this year by […]

Medtronic

TMVI heats up: Medtronic to drop $458m on Twelve’s mitral valve

Medtronic (NYSE:MDT) said today that it agreed to pony up as much as $458 million for Twelve Inc. and its transcatheter mitral valve implant, as the race to get a TMVI device to market heats up. Twelve, a spinout from the Foundry incubator that’s based in Redwood City, Calif., is backed by Domain Associates, Versant Ventures, Morgenthaler […]